Mika Scheinin

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 14

Top Venues

Diabetologia

The Journal of neuroscience : the official journal of the Society for Neuroscience

Nutrients

The Annals of pharmacotherapy

University of Turku (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

University of Turku

Finland

PHD :: Faculty of Medicine

Publications

Heikki Hyöty, Susanna Kääriäinen, Jutta E Laiho, Gail M Comer, Wei Tian, Taina Härkönen, Jussi P Lehtonen, Sami Oikarinen, Leena Puustinen, Michele Snyder, Francisco León, Mika Scheinin, Olli H Laitinen, Miguel Sanjuan
Safety, tolerability and immunogenicity of PRV-101, a multivalent vaccine targeting coxsackie B viruses (CVBs) associated with type 1 diabetes: a double-blind randomised placebo-controlled Phase I trial. Diabetologia 67 (5) (2024)
Heikki Hyöty, Susanna Kääriäinen, Jutta E Laiho, Gail M Comer, Wei Tian, Taina Härkönen, Jussi P Lehtonen, Sami Oikarinen, Leena Puustinen, Michele Snyder, Francisco León, Mika Scheinin, Olli H Laitinen, Miguel Sanjuan
Safety, tolerability and immunogenicity of PRV-101, a multivalent vaccine targeting coxsackie B viruses (CVBs) associated with type 1 diabetes: a double-blind randomised placebo-controlled Phase I trial. Diabetologia 67 (5) (2024)
Heikki Hyöty, Susanna Kääriäinen, Jutta E Laiho, Gail M Comer, Wei Tian, Taina Härkönen, Jussi P Lehtonen, Sami Oikarinen, Leena Puustinen, Michele Snyder, Francisco León, Mika Scheinin, Olli H Laitinen, Miguel Sanjuan
Safety, tolerability and immunogenicity of PRV-101, a multivalent vaccine targeting coxsackie B viruses (CVBs) associated with type 1 diabetes: a double-blind randomised placebo-controlled Phase I trial. Diabetologia 67 (5) (2024)
Heikki Hyöty, Susanna Kääriäinen, Jutta E Laiho, Gail M Comer, Wei Tian, Taina Härkönen, Jussi P Lehtonen, Sami Oikarinen, Leena Puustinen, Michele Snyder, Francisco León, Mika Scheinin, Olli H Laitinen, Miguel Sanjuan
Safety, tolerability and immunogenicity of PRV-101, a multivalent vaccine targeting coxsackie B viruses (CVBs) associated with type 1 diabetes: a double-blind randomised placebo-controlled Phase I trial. Diabetologia 67 (5) (2024)
Heikki Hyöty, Susanna Kääriäinen, Jutta E Laiho, Gail M Comer, Wei Tian, Taina Härkönen, Jussi P Lehtonen, Sami Oikarinen, Leena Puustinen, Michele Snyder, Francisco León, Mika Scheinin, Olli H Laitinen, Miguel Sanjuan
Safety, tolerability and immunogenicity of PRV-101, a multivalent vaccine targeting coxsackie B viruses (CVBs) associated with type 1 diabetes: a double-blind randomised placebo-controlled Phase I trial. Diabetologia 67 (5) (2024)
Heikki Hyöty, Susanna Kääriäinen, Jutta E Laiho, Gail M Comer, Wei Tian, Taina Härkönen, Jussi P Lehtonen, Sami Oikarinen, Leena Puustinen, Michele Snyder, Francisco León, Mika Scheinin, Olli H Laitinen, Miguel Sanjuan
Safety, tolerability and immunogenicity of PRV-101, a multivalent vaccine targeting coxsackie B viruses (CVBs) associated with type 1 diabetes: a double-blind randomised placebo-controlled Phase I trial. Diabetologia (2024)
Oskari Kantonen, Lauri Laaksonen, Michael Alkire, Annalotta Scheinin, Jaakko Långsjö, Roosa E Kallionpää, Kaike Kaisti, Linda Radek, Jarkko Johansson, Timo Laitio, Anu Maksimow, Mikko Nyman, Mika Scheinin, Olof Solin, Tero Vahlberg, Antti Revonsuo, Katja Valli
Decreased Thalamic Activity Is a Correlate for Disconnectedness During Anesthesia with Propofol, Dexmedetomidine and Sevoflurane but not S-Ketamine. The Journal of neuroscience : the official journal of the Society for Neuroscience (2023)
Mika Scheinin, Jouni J T Junnila, Giorgio Reiner, Anita MacDonald, Ania Carolina Muntau
Nitrogen Balance after the Administration of a Prolonged-Release Protein Substitute for Phenylketonuria as a Single Dose in Healthy Volunteers. Nutrients 13 (9) (2021)
Petri J Vainio, Pauliina Hietasalo, Anna-Liisa Koivisto, Susanna Kääriäinen, Jari Turunen, Mika Virtala, Jouni Vuorinen, Mika Scheinin
Hydroxychloroquine in the treatment of adult patients with Covid-19 infection in a primary care setting (LIBERTY): A structured summary of a study protocol for a randomised controlled trial. Trials 22 (1) (2021)
Muhammad W Ashraf, Panu Uusalo, Mika Scheinin, Teijo I Saari
Population Modelling of Dexmedetomidine Pharmacokinetics and Haemodynamic Effects After Intravenous and Subcutaneous Administration. Clinical pharmacokinetics 59 (11) (2021)
Mika Scheinin, Anna Barassi, Jouni J T Junnila, Zsófia Lovró, Giorgio Reiner, Essi Sarkkinen, Anita MacDonald
Amino Acid Plasma Profiles from a Prolonged-Release Protein Substitute for Phenylketonuria: A Randomized, Single-Dose, Four-Way Crossover Trial in Healthy Volunteers. Nutrients 12 (6) (2020)
Annalotta Scheinin, Oskari Kantonen, Michael Alkire, Jaakko Långsjö, Roosa E Kallionpää, Kaike Kaisti, Linda Radek, Jarkko Johansson, Nils Sandman, Mikko Nyman, Mika Scheinin, Tero Vahlberg, Antti Revonsuo, Katja Valli, Annalotta Scheinin
Foundations of Human Consciousness: Imaging the Twilight Zone. The Journal of neuroscience : the official journal of the Society for Neuroscience 41 (8) (2020)
Jenni Radun, Henna Maula, Ville Rajala, Mika Scheinin, Valtteri Hongisto
Speech is special: The stress effects of speech, noise, and silence during tasks requiring concentration. Indoor air 31 (1) (2020)
Joanna L Stollings, Jennifer L Thompson, Benjamin A Ferrell, Mika Scheinin, Grant R Wilkinson, Christopher G Hughes, Ayumi K Shintani, E Wesley Ely, Timothy D Girard, Pratik P Pandharipande, Mayur B Patel
Sedative Plasma Concentrations and Delirium Risk in Critical Illness. The Annals of pharmacotherapy 52 (6) (2018)

Mika Scheinin.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Mika Scheinin